在肺腺癌中B细胞免疫的作用
Long Shu1,2, Tania Tao2, Desheng Xiao3
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
B细胞在肺腺癌 (LUAD) 免疫力中起着至关重要的作用,与其他肺癌有很大不同. 了解B细胞功能是改善LUAD免疫疗法的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 肺癌,特别是肺腺癌 (LUAD),仍然是全球癌症相关死亡的主要原因.
- 虽然免疫检查点抑制剂 (ICI) 在LUAD治疗中表现有前途,但由于免疫检查点抑制剂的作用,应答率通常是有限的.
- 寒冷的瘤是一个瘤.
- 现型的特征是CD8+ T细胞透率低和PD-1表达.
- 研究瘤微环境中的其他免疫成分,如B细胞,对于开发更有效的免疫疗法至关重要.
研究的目的:
- 总结一下与其他肺癌亚型相比,LUAD中B细胞免疫的独特特征.
- 概述B细胞在LUAD背景下的多方面的作用及其对预后和免疫治疗反应的影响.
主要方法:
- 本综述综合了关于肺癌B细胞免疫学的当前科学文献.
- 介绍了LUAD和肺状细胞癌 (LUSC) 之间的B细胞丰度,活性和预后意义的比较分析.
主要成果:
- 与LUSC相比,B细胞在LUAD中表现出更高的患病率,活性和预后相关性.
- 最近的研究强调了B细胞存在与免疫疗法在各种固体瘤 (包括肺癌) 的有效性之间的显著相关性.
结论:
- B细胞免疫在LUAD中呈现出独特的特征,与其他肺癌类型不同.
- 在LUAD瘤微环境中进一步阐明B细胞功能对于推进新型免疫治疗策略至关重要.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
相关概念视频
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cell-mediated Immune Responses
Tumor Immunotherapy
Cells of the Adaptive Immune Response
